...
首页> 外文期刊>Journal of Medicinal Chemistry >A selective human H(4)-receptor agonist: (-)-2-cyano-1-methyl-3-((2R,5R)-5- (1H-imidazol-4(5)-yl)tetrahydrofuran-2-y) methylguanidine.
【24h】

A selective human H(4)-receptor agonist: (-)-2-cyano-1-methyl-3-((2R,5R)-5- (1H-imidazol-4(5)-yl)tetrahydrofuran-2-y) methylguanidine.

机译:选择性人类H(4)-受体激动剂:(-)-2-氰基-1-甲基-3-((2R,5R)-5-(1H-咪唑-4(5)-基)四氢呋喃-2- y)甲基胍。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A series of 16 compounds related to chiral 4(5)-(5-aminomethyltetrahydrofuran-2-yl)imidazoles (1) have been designed, synthesized, and examined in vitro by radioligand displacement studies and functional assays for both the human H(3)- and H(4)-receptors expressed in SK-N-MC cells. Among them, the (2S,5S)-isomer 1d of amino compounds showed approximately 300-fold higher selectivity at the H(3)-receptor than the H(4)-receptor. On the other hand, (2R,5S)- and (2R,5R)-cyanoguanidines 3b and 3c, in which the amino group of the compounds 1b and 1c was substituted by the cyanoguanidino moiety, bound to the H(4)-receptor with a pEC(50) value of 6.65 and 7.11, respectively, and had >40-fold selectivities over the H(3)-receptor. As such, 3b and 3c are the first selective H(4) receptor agonists.
机译:已设计,合成并通过放射性配体置换研究和人H(3)的功能测定体外检查了一系列与手性4(5)-(5-氨基甲基四氢呋喃-2-基)咪唑(1)相关的16种化合物)和H(4)-受体在SK-N-MC细胞中表达。其中,氨基化合物的(2S,5S)异构体1d在H(3)受体处的选择性比H(4)受体高约300倍。另一方面,(2R,5S)-和(2R,5R)-氰基胍3b和3c与H(4)-受体结合,其中化合物1b和1c的氨基被氰基胍基部分取代。的pEC(50)值分别为6.65和7.11,并且在H(3)受体上具有> 40倍的选择性。这样,3b和3c是第一个选择性H(4)受体激动剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号